National Holdings will remain a publicly traded company as Fortress Biotech Inc. affiliate FBIO Acquisition Inc.'s tender offer has failed to secure 80% of the company's stock. After FBIO Acquisition accepted the shares, the size of the National Holdings board was cut to seven members. Eight of the current board members resigned, and the five individuals chosen by Fortress were added to the National Holdings board. National Holdings' board now consists of current directors Robert Fagenson and Mark Goldwasser and the Fortress designees, Michael Eustace, Neil Herskowitz, Daniel Hume, Michael Weiss and Eli Salig.